Spotlight on the utility of the Oncotype DX® breast cancer assay.

about

Spotlight on the utility of the Oncotype DX® breast cancer assay.

Item

http://www.wikidata.org/entity/Q52728983

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@en

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@nl

type

Item

label

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@en

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@nl

prefLabel

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@en

Spotlight on the utility of the Oncotype DX® breast cancer assay.

@nl

P1476

Spotlight on the utility of the Oncotype DX® breast cancer assay

@en

P2093

G Bruce Mann

http://www.w3.org/2001/XMLSchema#string

Richard H De Boer

http://www.w3.org/2001/XMLSchema#string

Zhen Rong Siow

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

The Ki-67 protein: from the known and the unknown

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Supervised risk predictor of breast cancer based on intrinsic subtypes

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

P304

89-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJWH.S124520

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey J. Lindeman

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29503586

http://www.w3.org/2001/XMLSchema#string

P932

5827461

http://www.w3.org/2001/XMLSchema#string